Skip to main content
. 2011 Aug;55(8):3720–3728. doi: 10.1128/AAC.00322-11

Fig. 4.

Fig. 4.

Effect of the lung surfactant on MICs of MX-2401, daptomycin, and vancomycin against MRSA (A) and PRSP (B). The changes of antimicrobial activity in the presence of surfactant are expressed as MICsurfactant/MICno surfactant ratios.